47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.90.Z - Non-specialized wholesale trade
47.12.Z - Other non-specialized retail trade
47.27.Z - Retail trade of other food products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 4,3 | 3,2 | 3 | -6,3 |
EBITDA | 5,1 | 3,9 | 3,7 | -5,4 |
Short time liabilities | 9,7 | 9,9 | 9 | -8,6 |
Equity capital | 4,6 | 5,9 | 7 | 16,9 |
Operating profit (EBIT) | 4,4 | 3,3 | 3,1 | -5,4 |
Assets | 14,8 | 15,9 | 16 | 0,5 |
Net profit (loss) | 4,3 | 3,2 | 3 | -6,3 |
Cash | 0,4 | 0,5 | 0,2 | -58,9 |
Liabilities and provisions for liabilities | 10,2 | 9,9 | 9 | -9,4 |
Net income from sale | 65,5 | 72,5 | 75,2 | 3,7 |
Working assets | 6,5 | 8 | 8,5 | 5,8 |
Depreciation | 0,7 | 0,6 | 0,6 | -5,3 |
% | % | % | p.p. | |
Profitability of capital | 92,1 | 54,2 | 43,4 | -10,8 |
Equity capital to total assets | 31,3 | 37,4 | 43,6 | 6,2 |
Gross profit margin | 6,5 | 4,4 | 4 | -0,4 |
EBITDA Margin | 7,9 | 5,4 | 5 | -0,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 54 | 50 | 44 | -6 |
Current financial liquidity indicator | 0.6712950468063354 | 0.8104345798492432 | 0.9395104646682739 | 0,1 |
Net dept to EBITDA | 0.2368754744529724 | 0.11216990649700165 | 0.09652518481016159 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane